Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1976 1
1979 1
1981 2
1982 1
1983 2
1984 1
1985 4
1986 6
1987 1
1988 5
1989 6
1990 3
1991 8
1992 10
1993 10
1994 15
1995 11
1996 19
1997 20
1998 30
1999 23
2000 29
2001 30
2002 30
2003 48
2004 64
2005 51
2006 48
2007 63
2008 67
2009 90
2010 72
2011 64
2012 98
2013 92
2014 103
2015 112
2016 143
2017 134
2018 89
2019 69
2020 86
2021 93
2022 102
2023 100
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

1,887 results

Results by year

Filters applied: . Clear all
Page 1
Chronic Kidney Disease Diagnosis and Management: A Review.
Chen TK, Knicely DH, Grams ME. Chen TK, et al. JAMA. 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745. JAMA. 2019. PMID: 31573641 Free PMC article. Review.
IMPORTANCE: Chronic kidney disease (CKD) is the 16th leading cause of years of life lost worldwide. Appropriate screening, diagnosis, and management by primary care clinicians are necessary to prevent adverse CKD-associated outcomes, including cardiovascular …
IMPORTANCE: Chronic kidney disease (CKD) is the 16th leading cause of years of life lost worldwide. Appropriate screeni …
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.
Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD. Hill NR, et al. PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016. PLoS One. 2016. PMID: 27383068 Free PMC article. Review.
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and is an independent risk factor for cardiovascular disease (CVD). ...Global mean(95%CI) CKD prevalence of 5 stages 13.4%(11.7-15.1%), and …
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and is an independen …
Targeting the progression of chronic kidney disease.
Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Ruiz-Ortega M, et al. Nat Rev Nephrol. 2020 May;16(5):269-288. doi: 10.1038/s41581-019-0248-y. Epub 2020 Feb 14. Nat Rev Nephrol. 2020. PMID: 32060481 Review.
Chronic kidney disease (CKD) is a devastating condition that is reaching epidemic levels owing to the increasing prevalence of diabetes mellitus, hypertension and obesity, as well as ageing of the population. Regardless of the underlying aetiology, CKD is slo …
Chronic kidney disease (CKD) is a devastating condition that is reaching epidemic levels owing to the increasing preval …
Iron Deficiency Anemia in Chronic Kidney Disease.
Gafter-Gvili A, Schechter A, Rozen-Zvi B. Gafter-Gvili A, et al. Acta Haematol. 2019;142(1):44-50. doi: 10.1159/000496492. Epub 2019 Apr 10. Acta Haematol. 2019. PMID: 30970355 Free article. Review.
Iron deficiency anemia is a common complication of chronic kidney disease (CKD). CKD patients suffer from both absolute and functional iron deficiency. ...There is general agreement according to guidelines that intravenous (i.v.) iron supplementation is the p …
Iron deficiency anemia is a common complication of chronic kidney disease (CKD). CKD patients suffer from both absolute …
Hypertension and the kidneys.
De Bhailis ÁM, Kalra PA. De Bhailis ÁM, et al. Br J Hosp Med (Lond). 2022 May 2;83(5):1-11. doi: 10.12968/hmed.2021.0440. Epub 2022 May 27. Br J Hosp Med (Lond). 2022. PMID: 35653320 Free article. Review.
Hypertension is a leading risk factor for cardiovascular disease and all-cause mortality globally. Hypertension and chronic kidney disease are closely intertwined conditions as hypertension can lead to deteriorating renal function and progressiv …
Hypertension is a leading risk factor for cardiovascular disease and all-cause mortality globally. Hypertension and chronic …
Adenine-induced chronic kidney disease in rats.
Diwan V, Brown L, Gobe GC. Diwan V, et al. Nephrology (Carlton). 2018 Jan;23(1):5-11. doi: 10.1111/nep.13180. Nephrology (Carlton). 2018. PMID: 29030945 Review.
Many animal models have been developed to study the causes and treatments of chronic kidney disease (CKD) in humans, an insidious disease resulting from kidney injury and characterized by persistent functional decline for more than 3 months, wit …
Many animal models have been developed to study the causes and treatments of chronic kidney disease (CKD) in humans, an …
Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
Galindo RJ, Beck RW, Scioscia MF, Umpierrez GE, Tuttle KR. Galindo RJ, et al. Endocr Rev. 2020 Oct 1;41(5):756-74. doi: 10.1210/endrev/bnaa017. Endocr Rev. 2020. PMID: 32455432 Free PMC article. Review.
Glucose and insulin metabolism in patients with diabetes are profoundly altered by advanced chronic kidney disease (CKD). Risk of hypoglycemia is increased by failure of kidney gluconeogenesis, impaired insulin clearance by the kidney, defective …
Glucose and insulin metabolism in patients with diabetes are profoundly altered by advanced chronic kidney disease (CKD …
Management of Heart Failure Patient with CKD.
Banerjee D, Rosano G, Herzog CA. Banerjee D, et al. Clin J Am Soc Nephrol. 2021 Jul;16(7):1131-1139. doi: 10.2215/CJN.14180920. Epub 2021 Jan 25. Clin J Am Soc Nephrol. 2021. PMID: 33495289 Free PMC article. Review.
Evidence for treatment with beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, angiotensin receptor neprilysin inhibitors, and sodium-glucose cotransporter inhibitors in mild-to-moderate CKD has emerged from general population studies in patie …
Evidence for treatment with beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, angiotensin receptor nep …
Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.
Beldhuis IE, Lam CSP, Testani JM, Voors AA, Van Spall HGC, Ter Maaten JM, Damman K. Beldhuis IE, et al. Circulation. 2022 Mar;145(9):693-712. doi: 10.1161/CIRCULATIONAHA.121.052792. Epub 2022 Feb 28. Circulation. 2022. PMID: 35226558 Free PMC article. Review.
Chronic kidney disease (CKD) as identified by a reduced estimated glomerular filtration rate (eGFR) is a common comorbidity in patients with heart failure with reduced ejection fraction (HFrEF). ...Data are lacking on the safety and efficacy for any HFrEF the …
Chronic kidney disease (CKD) as identified by a reduced estimated glomerular filtration rate (eGFR) is a common comorbi …
Kidney and heart failure outcomes associated with SGLT2 inhibitor use.
van der Aart-van der Beek AB, de Boer RA, Heerspink HJL. van der Aart-van der Beek AB, et al. Nat Rev Nephrol. 2022 May;18(5):294-306. doi: 10.1038/s41581-022-00535-6. Epub 2022 Feb 10. Nat Rev Nephrol. 2022. PMID: 35145275 Review.
Chronic kidney disease (CKD) and heart failure affect many people worldwide. ...After observations that sodium-glucose co-transporter 2 (SGLT2) inhibitors - originally developed as glucose-lowering agents - improved cardiovascular and renal outcomes in …
Chronic kidney disease (CKD) and heart failure affect many people worldwide. ...After observations that sodium-glucose …
1,887 results